BG Medicine this week filed an amendment to the preliminary prospectus for its initial public offering, estimating that it will raise around $67 million from selling 4.75 million shares at an offering price between $13 and $15 per share.
BG Medicine Aims to Raise $67M in IPO; Continues Transition from Services to Diagnostics Development
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.